Tag: CDMO
Advantage Health Care – India 2026: Medical Value Travel acts as...
Advantage Healthcare India 2026 aims to foster patient mobility, knowledge exchange, skill development and institutional partnerships,
Hikal inaugurates HPAPI Lab at its Pune Innovation Centre
The facility has been designed with a range of advanced features to ensure both safety and efficiency
Aragen appoints Aniel Khubchandani as CEO of Development & Manufacturing Solutions...
Aniel will be a member of Aragen’s Management Council and will be based in Hyderabad
Yann D’Herve joins Cohance Lifesciences as CEO – CDMO Business
Effective August 1, 2025, D’Herve’s appointment brings a strong track record of senior-level leadership to Cohance
Zydus enters global biologics CDMO business, plans to acquire Agenus’ U.S....
This acquisition positions Zydus at the forefront of the fast-growing global biologics CDMO market, establishing a robust presence in the world’s leading biotech innovation hub
Shilpa Biologicals opens bioconjugation manufacturing site at Dharwad
New bioconjugation services to complete the CDMO’s end-to-end capabilities across payload, linker, and MAb
FDA drug approvals drop 15.44% but smaller pharma leads innovation, reveals...
GlobalData’s Bio/Pharmaceutical Outsourcing report sheds light on the reliance of smaller pharma companies on contract development and manufacturing organizations (CDMOs) for production
India Biotech Outlook 2025: The India Advantage at BIO Boston 2025
BioVoice News and the International Contract Pharma Association (ICPA) have collaborated to present an exclusive publication that will highlight India’s leadership in biotech and provide a powerful platform for companies to maximize their presence
Shilpa Medicare launches ‘hybrid CDMO’ at DCAT
Integrated CDMO has capabilities spanning small and large molecules as well as peptides with ‘off-the-shelf’ commercially ready formulations for license
Jubilant Biosys seals deal with Pierre Fabre SA
To acquire R&D center at Saint-Julien-en-Genevois, France